Clinical efficacy of 1% Alendronate gel in adjunct to mechanotherapy in the treatment of aggressive periodontitis: A randomized controlled clinical trial

Journal of Periodontology

Volumn 83, Issue 1, 2012, Pages 19-26

  Shar, Anuj ^a   Pradeep, A R ^a  

^a Government Dental College and Research Institute   (India)

Author keywords

Aggressive periodontitis; Alendronate; Regeneration

Indexed keywords

ALENDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

ADULT; AGGRESSIVE PERIODONTITIS; ALVEOLAR BONE LOSS; ARTICLE; BONE REGENERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; GEL; HUMAN; IMAGE PROCESSING; MALE; PERIODONTICS; PREVENTIVE DENTISTRY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGGRESSIVE PERIODONTITIS; ALENDRONATE; ALVEOLAR BONE LOSS; BONE DENSITY CONSERVATION AGENTS; BONE REGENERATION; DENTAL SCALING; DRUG DELIVERY SYSTEMS; FEMALE; GELS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; PERIODONTAL INDEX; YOUNG ADULT;

EID: 84856002448     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2011.110206     Document Type: Article

References (46)

1. Lang N, Barthold PM, Cullinan M, et al. Consensus report: Aggressive periodontitis. Ann Periodontol 1999; 4:53.
2. Armitage GC. Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000 2004;34:9-21. (Pubitemid 41794526)
3. Armitage GC, Cullinan MP. Comparison of the clinical features of chronic and aggressive periodontitis. Periodontol 2000 2010;53:12-27.
4. Armitage GC, Cullinan MP, Seymour GJ. Comparative biology of chronic and aggressive periodontitis: Introduction. Periodontol 2000 2010;53:7-11.
5. Kinane DF, Hart TC. Genes and gene polymorphisms associated with periodontal disease. Crit Rev Oral Biol Med 2003;14:430-449. (Pubitemid 44567529)
6. Kamma JJ, Baehni PC. Five-year maintenance followup of early-onset periodontitis patients. J Clin Periodontol 2003;30:562-572. (Pubitemid 38011187)
7. Wennström A, Wennström J, Lindhe J. Healing following surgical and non-surgical treatment of juvenile periodontitis. A 5-year longitudinal study. J Clin Periodontol 1986;13:869-882.
8. Buchmann R, Nunn ME, Van Dyke TE, Lange DE. Aggressive periodontitis: 5-year follow-up of treatment. J Periodontol 2002;73:675-683. (Pubitemid 34679084)
9. Reddy MS, Geurs NC, Gunsolley JC. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. Ann Periodontol 2003;8:12-37.
10. Hwang JS, Liou MJ, Ho C, et al. The effects of weekly alendronate therapy in Taiwanese males with osteoporosis. J Bone Miner Metab 2010;28:328-333.
11. Jeffcoat MK, Cizza G, Shih WJ, Genco R, Lombardi A. Efficacy of bisphosphonates for the control of alveolar bone loss in periodontitis. J Int Acad Periodontol 2007; 9:70-76.
12. El-Shinnawi UM, El-Tantawy SI. The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial). J Int Acad Periodontol 2003;5:5-10.
13. Lane N, Armitage GC, Loomer P, et al. Bisphosphonate therapy improves the outcome of conventional periodontal treatment: Results of a 12-month, randomized, placebo-controlled study. J Periodontol 2005;76: 1113-1122. (Pubitemid 41065401)
14. Menezes AM, Rocha FA, Chaves HV, Carvalho CB, Ribeiro RA, Brito GA. Effect of sodium alendronate on alveolar bone resorption in experimental periodontitis in rats. J Periodontol 2005;76:1901-1909. (Pubitemid 41748979)
15. Reddy MS, Weatherford TW 3rd, Smith CA, West BD, Jeffcoat MK, Jacks TM. Alendronate treatment of naturally-occurring periodontitis in beagle dogs. J Periodontol 1995;66:211-217.
16. Weinreb M, Quartuccio H, Seedor JG, et al. Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkeys. J Periodontal Res 1994;29: 35-40.
17. Yaffe A, Fine N, Alt I, Binderman I. Effect of bisphosphonate on alveolar bone resorption following mucoperiosteal flap surgery in the mandible of rats. J Periodontol 1995;66:999-1003.
18. Yaffe A, Fine N, Binderman I. Regional accelerated phenomenon in the mandible following mucoperiosteal flap surgery. J Periodontol 1994;65:79-83.
19. Reddy GT, Kumar TM, Veena KM. Formulation and evaluation of alendronate sodium gel for the treatment of bone resorptive lesions in periodontitis. Drug Deliv 2005;12:217-222. (Pubitemid 40981284)
20. Binderman I, Adut M, Yaffe A. Effectiveness of local delivery of alendronate in reducing alveolar bone loss following periodontal surgery in rats. J Periodontol 2000;71:1236-1240. (Pubitemid 30655955)
21. Yaffe A, Iztkovich M, Earon Y, Alt I, Lilov R, Binderman I. Local delivery of an amino bisphosphonate prevents the resorptive phase of alveolar bone following mucoperiosteal flap surgery in rats. J Periodontol 1997;68:884-889. (Pubitemid 27411022)
22. Sharma A, Pradeep AR. Clinical efficacy of 1% alendronate gel as a local drug delivery system in the treatment of chronic periodontitis: A randomized controlled clinical trial. J Periodontol 2012;83:11-18.
23. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
24. Mombelli A, van Oosten MA, Schurch E, Lang NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol 1987;2:145-151.
25. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
26. Pradeep AR, Sharma A. Autologous platelet rich fibrin in the treatment of mandibular Degree II furcation defects: A randomized clinical trial. J Periodontol 2011; 82:1396-1403.
27. Brunsvold MA, Chaves ES, Kornman KS, Aufdemorte TB, Wood R. Effects of a bisphosphonate on experimental periodontitis in monkeys. J Periodontol 1992; 63:825-830.
28. Rocha M, Nava LE, Vázquez de la Torre C, Sánchez- Márin F, Garay-Sevilla ME, Malacara JM. Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: A randomized, placebo-controlled trial. J Periodontol 2001;72:204-209.
29. Kleinfelder JW, Sculean A, Lange DE. Some effects of non-surgical therapy on gingival inflammatory cell subsets in patients with early-onset periodontitis associated with Actinobacillus actinomycetemcomitans. J Periodontol 2001;72:1713-1719. (Pubitemid 34092737)
30. Pawlowski AP, Chen A, Hacker BM, Mancl LA, Page RC, Roberts FA. Clinical effects of scaling and root planning on untreated teeth. J Clin Periodontol 2005;32:21-28. (Pubitemid 40187421)
31. Dosumu EB, Arowojolu MO, Savage KO. Alveolar bone regeneration pattern following surgical and nonsurgical treatment in juvenile periodontitis. West Afr J Med 2002;21:272-275.
32. Tenenbaum HC, Shelemay A, Girard B, Zohar R, Fritz PC. Bisphosphonates and periodontics: Potential applications for regulation of bone mass in the periodontium and other therapeutic/diagnostic uses. J Periodontol 2002;73:813-822.
33. Hughes DE, Wright KR, Uy HL, et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 1995;10:1478-1487.
34. Sato M, Grasser W. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy. J Bone Miner Res 1990;5:31-40. (Pubitemid 20089901)
35. Hughes DE, MacDonald BR, Russell RG, Gowen M. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest 1989;83:1930-1935. (Pubitemid 19148862)
36. VittéC, Fleisch H, Guenther HL. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinology 1996;137:2324-2333.
37. Colucci S, Minielli V, Zambonin G, et al. Alendronate reduces adhesion of human osteoclast-like cells to bone and bone protein-coated surfaces. Calcif Tissue Int 1998;63:230-235. (Pubitemid 28387975)
38. Teronen O, HeikkiläP, Konttinen YT, et al. MMP inhibition and downregulation by bisphosphonates. Ann N Y Acad Sci 1999;878:453-465. (Pubitemid 29353588)
39. Giuliani N, Pedrazzoni M, Passeri G, Girasole G. Bisphosphonates inhibit IL-6 production by human osteoblast-like cells. Scand J Rheumatol 1998;27:38-41. (Pubitemid 28116468)
40. Giuliani N, Pedrazzoni M, Negri G, Passeri G, Impicciatore M, Girasole G. Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Bone 1998;22:455-461.
41. Needleman IG, Pandya NV, Smith SR, Foyle DM. The role of antibiotics in the treatment of periodontitis. Part 2: Controlled drug delivery. Eur J Prosthodont Restor Dent 1995;3:111-117.
42. Fleisch H. Bisphosphonates -Preclinical. In: Bisphosphonates in Bone Disease: From the Laboratory to the Patient. San Diego: Academic Press; 2000:34-55.
43. Jones DS, Brown AF, Woolfson AD. Rheological characterization of bioadhesive, antimicrobial, semisolids designed for the treatment of periodontal diseases: Transient and dynamic viscoelastic and continuous shear analysis. J Pharm Sci 2001;90:1978-1990. (Pubitemid 33144444)
44. Perioli L, Ambrogi V, Rubini D, et al. Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. J Control Release 2004;95:521-533. (Pubitemid 38340502)
45. Jones DS, Woolfson AD, Djokic J, Coulter WA. Development andmechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm Res 1996;13:1734-1738. (Pubitemid 26426902)
46. Bansal K, Rawat MK, Jain A, Rajput A, Chaturvedi TP, Singh S. Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS PharmSci-Tech 2009;10:716-723.